PDE6B and retinitis pigmentosa 1: The first proof-of-principle of this strategy in the visual system was demonstrated using CRISPR-Cas9-mediated HDR to enable editing of the mutated Pde6b gene in the retina of the “rodless” [rd1] mouse, the most studied model of RP.